E. Borghesio

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.

M. Manns, T. Philipp, F. V. van Pelt, 1995, Gastroenterology.

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency.

E. Sagnelli, M. Milella, A. Benedetti, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

Fabio Macciardi, Angelo Andriulli, Nicola Caporaso, 2010, Nature Genetics.

Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?

M. Astegiano, G. Touscoz, F. Rosina, 1995, European journal of gastroenterology & hepatology.

Osteoporosis: still a typical complication of primary biliary cirrhosis?

M. Rizzetto, G. Isaia, M. di Stefano, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Liver, Pancreas and Biliary Tract O still a typical complication of primary biliary cirrhosis?

M. Stefano, M. Rizzetto, G. Isaia, 2003 .

LCT-13910C>T polymorphism-associated lactose malabsorption and risk for colorectal cancer in Italy.

G. Actis, E. Tarabra, G. Tappero, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P.03.8 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY

A. Gasbarrini, M. Rizzetto, G. Minoli, 2012 .

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.

A. Andriulli, A. Mangia, M. Rizzetto, 1997, Journal of hepatology.

Sequential versus concomitant administration of ribavirin and interferon alfa‐n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial

M. Rizzetto, G. Saracco, V. Ghisetti, 1998, Hepatology.

Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation

M. Rizzetto, A. Smedile, F. Rosina, 1998, Hepatology.

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency.

E. Sagnelli, M. Milella, A. Benedetti, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.